Your browser doesn't support javascript.
loading
The Role of Treatment Sequencing with Immune-Checkpoint Inhibitors and BRAF/MEK Inhibitors for Response and Survival of Patients with BRAFV600-Mutant Metastatic Melanoma-A Retrospective, Real-World Cohort Study.
Haist, Maximilian; Stege, Henner; Ebner, Ronja; Fleischer, Maria Isabel; Loquai, Carmen; Grabbe, Stephan.
Affiliation
  • Haist M; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
  • Stege H; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
  • Ebner R; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
  • Fleischer MI; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
  • Loquai C; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
  • Grabbe S; Department of Dermatology, University Medical Center Mainz, 55131 Mainz, Germany.
Cancers (Basel) ; 14(9)2022 Apr 21.
Article in En | MEDLINE | ID: mdl-35565212
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2022 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2022 Type: Article Affiliation country: Germany